Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

Measurable (minimal) residual disease (MRD) is an established, key prognostic factor in adult B-cell acute lymphoblastic leukemia (B-ALL), and testing for MRD is known to be an important tool to help guide treatment decisions. The clinical value of MRD testing depends on the accuracy and reliability...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anne Tierens, Tracy L. Stockley, Clinton Campbell, Jill Fulcher, Brian Leber, Elizabeth McCready, Peter J. B. Sabatini, Bekim Sadikovic, Andre C. Schuh
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-03-01
Col·lecció:	Current Oncology
Matèries:	adult B-cell acute lymphoblastic leukemia adult acute lymphoblastic leukemia flow cytometry minimal residual disease measurable residual disease next-generation sequencing
Accés en línia:	https://www.mdpi.com/1718-7729/28/2/131
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!